世界の核酸増幅検査(NAAT)市場2020年ー2027年:技術別(ターゲット増幅システム、プローブ増幅システム、シグナル増幅システム)、用途別、地域別

◆英語タイトル:Global Nucleic Acid Amplification Testing (NAAT) Market Size study, by Technique (Target Amplification Systems, Probe Amplification Systems, Signal Amplification Systems), by Application (Infectious Disease, Cancer, Others) and Regional Forecasts 2020-2027
◆商品コード:BZW21FB010
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2021年1月20日
◆ページ数:約200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:米国、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、GCC諸国
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥564,300見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥712,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

Bizwit Research社の本調査資料では、世界の核酸増幅検査(NAAT)市場を広く調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、技術別(ターゲット増幅システム、プローブ増幅システム、シグナル増幅システム)分析、用途別(感染症、癌、その他)分析、地域別分析、競争状況、調査プロセスなど、以下の構成でまとめております。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・世界の核酸増幅検査(NAAT)市場規模:技術別(ターゲット増幅システム、プローブ増幅システム、シグナル増幅システム)
・世界の核酸増幅検査(NAAT)市場規模:用途別(感染症、癌、その他)
・世界の核酸増幅検査(NAAT)市場規模:地域別
・競争状況
・調査プロセス
【レポートの概要】

Global Nucleic Acid Amplification Testing (NAAT) Market is valued at approximately USD 2.5 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 10.4% over the forecast period 2020-2027. Nucleic Acid Amplification Test (NAAT) is an innovative technique used for the identification of a specific nucleic acid, bacteria, or virus, that act as a disease-causing pathogen from biologic samples, such as urine, tissues. etc. Furthermore, this technique is often utilized for blood screening donations to mitigate the risk of transfusion-transmitted infections in the recipients. Besides, nucleic acid amplification test is the precise detection technique used for most of the infectious agents, as it helps diagnose and improve patients care in high-income countries. Thus, it is extensively adopted over conventional diagnostic techniques for treating and curing infectious diseases, such as HIV and Ebola. According to the Joint United Nations Programme on HIV and AIDS (UNAIDS), in 2019, nearly 1.7 million individuals were newly affected by HIV , compared to a 2.8 million adult population in 1998. Thus, the rise in prevalence of HIV diseases throughout the world will foster the adoption for NAAT in the forthcoming period. Along with infectious diseases, NAAT is being extensively used across numerous other fields, including cancer, personalized medicine, and forensics. This is likely to spur the adoption & utility for NAAT during the forecast period. In addition, the rise in expenditure or investment in pharmaceutical and biopharmaceutical sector, along with escalating demand for the advanced diagnostic measure are the few factors responsible for the high CAGR of the market during the forecast period. For instance, the Association of the British Pharmaceutical Industry (ABPI) estimated that the biopharmaceutical companies worldwide spent around USD 156.7 billion on R&D activities in 2016, representing an increase from USD 148 billion in 2015. Further , it is likely to grow around USD 181 billion by the year 2022. This, in turn, is likely to strengthen the demand for nucleic acid amplification testing (NAAT), thereby contributing to the market growth around the world. However, the high cost of test and shortage of skilled professionals are the major factors restraining the market growth over the forecast period 2020-2027.

The regional analysis of the global Nucleic Acid Amplification Testing (NAAT) market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising government support to implement Nucleic Acid Amplification Testing (NAAT), along with the significant presence of market vendors in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in prevalence of life-threatening diseases and infectious diseases and rising adoption of innovative diagnostic technologies in the developing nations, such as China and India, are the few factors creating a lucrative opportunity for the growth of the Nucleic Acid Amplification Testing (NAAT) market in the Asia-Pacific region.

Major market player included in this report are:
Abbott Laboratories
Becton, Dickinson and Company
BioMérieux S.A.
Bio-Rad Laboratories, Inc.
Grifols, S.A.
F. Hoffmann-La Roche AG
Hologic, Inc.
Illumina, Inc.
Beckman Coulter, Inc.
Siemens Healthcare GmbH

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technique:
Target Amplification Systems
Probe Amplification Systems
Signal Amplification Systems

By Application:
Infectious Disease
Cancer
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Nucleic Acid Amplification Testing (NAAT) Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Nucleic Acid Amplification Testing (NAAT) Market, by Region, 2018-2027 (USD Billion)
1.2.2. Nucleic Acid Amplification Testing (NAAT) Market, by Technique, 2018-2027 (USD Billion)
1.2.3. Nucleic Acid Amplification Testing (NAAT) Market, by Application, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Nucleic Acid Amplification Testing (NAAT) Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Nucleic Acid Amplification Testing (NAAT) Market Dynamics
3.1. Nucleic Acid Amplification Testing (NAAT) Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Nucleic Acid Amplification Testing (NAAT) Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Nucleic Acid Amplification Testing (NAAT) Market, by Technique
5.1. Market Snapshot
5.2. Global Nucleic Acid Amplification Testing (NAAT) Market by Technique, Performance – Potential Analysis
5.3. Global Nucleic Acid Amplification Testing (NAAT) Market Estimates & Forecasts by Technique 2017-2027 (USD Billion)
5.4. Nucleic Acid Amplification Testing (NAAT) Market, Sub Segment Analysis
5.4.1. Target Amplification Systems
5.4.2. Probe Amplification Systems
5.4.3. Signal Amplification Systems
Chapter 6. Global Nucleic Acid Amplification Testing (NAAT) Market, by Application
6.1. Market Snapshot
6.2. Global Nucleic Acid Amplification Testing (NAAT) Market by Application, Performance – Potential Analysis
6.3. Global Nucleic Acid Amplification Testing (NAAT) Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
6.4. Nucleic Acid Amplification Testing (NAAT) Market, Sub Segment Analysis
6.4.1. Infectious Disease
6.4.2. Cancer
6.4.3. Others
Chapter 7. Global Nucleic Acid Amplification Testing (NAAT) Market, Regional Analysis
7.1. Nucleic Acid Amplification Testing (NAAT) Market, Regional Market Snapshot
7.2. North America Nucleic Acid Amplification Testing (NAAT) Market
7.2.1. U.S. Nucleic Acid Amplification Testing (NAAT) Market
7.2.1.1. Technique breakdown estimates & forecasts, 2017-2027
7.2.1.2. Application breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Nucleic Acid Amplification Testing (NAAT) Market
7.3. Europe Nucleic Acid Amplification Testing (NAAT) Market Snapshot
7.3.1. U.K. Nucleic Acid Amplification Testing (NAAT) Market
7.3.2. Germany Nucleic Acid Amplification Testing (NAAT) Market
7.3.3. France Nucleic Acid Amplification Testing (NAAT) Market
7.3.4. Spain Nucleic Acid Amplification Testing (NAAT) Market
7.3.5. Italy Nucleic Acid Amplification Testing (NAAT) Market
7.3.6. Rest of Europe Nucleic Acid Amplification Testing (NAAT) Market
7.4. Asia-Pacific Nucleic Acid Amplification Testing (NAAT) Market Snapshot
7.4.1. China Nucleic Acid Amplification Testing (NAAT) Market
7.4.2. India Nucleic Acid Amplification Testing (NAAT) Market
7.4.3. Japan Nucleic Acid Amplification Testing (NAAT) Market
7.4.4. Australia Nucleic Acid Amplification Testing (NAAT) Market
7.4.5. South Korea Nucleic Acid Amplification Testing (NAAT) Market
7.4.6. Rest of Asia Pacific Nucleic Acid Amplification Testing (NAAT) Market
7.5. Latin America Nucleic Acid Amplification Testing (NAAT) Market Snapshot
7.5.1. Brazil Nucleic Acid Amplification Testing (NAAT) Market
7.5.2. Mexico Nucleic Acid Amplification Testing (NAAT) Market
7.6. Rest of The World Nucleic Acid Amplification Testing (NAAT) Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Abbott Laboratories
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Becton, Dickinson and Company
8.2.3. BioMérieux S.A.
8.2.4. Bio-Rad Laboratories, Inc.
8.2.5. Grifols, S.A.
8.2.6. F. Hoffmann-La Roche AG
8.2.7. Hologic, Inc.
8.2.8. Illumina, Inc.
8.2.9. Beckman Coulter, Inc.
8.2.10. Siemens Healthcare GmbH
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

List of Tables
TABLE 1. Global Nucleic Acid Amplification Testing (NAAT) market, report scope
TABLE 2. Global Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by region 2017-2027 (USD Billion)
TABLE 3. Global Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by Technique 2017-2027 (USD Billion)
TABLE 4. Global Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by Application 2017-2027 (USD Billion)
TABLE 5. Global Nucleic Acid Amplification Testing (NAAT) market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 6. Global Nucleic Acid Amplification Testing (NAAT) market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 7. Global Nucleic Acid Amplification Testing (NAAT) market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 8. Global Nucleic Acid Amplification Testing (NAAT) market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 9. Global Nucleic Acid Amplification Testing (NAAT) market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 10. Global Nucleic Acid Amplification Testing (NAAT) market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 11. Global Nucleic Acid Amplification Testing (NAAT) market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 12. Global Nucleic Acid Amplification Testing (NAAT) market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 13. Global Nucleic Acid Amplification Testing (NAAT) market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 14. Global Nucleic Acid Amplification Testing (NAAT) market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 15. Global Nucleic Acid Amplification Testing (NAAT) market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 16. Global Nucleic Acid Amplification Testing (NAAT) market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 17. Global Nucleic Acid Amplification Testing (NAAT) market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 18. Global Nucleic Acid Amplification Testing (NAAT) market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 19. Global Nucleic Acid Amplification Testing (NAAT) market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 20. Global Nucleic Acid Amplification Testing (NAAT) market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 21. U.S. Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 22. U.S. Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 23. U.S. Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 24. Canada Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 25. Canada Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 26. Canada Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 27. UK Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 28. UK Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 29. UK Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 30. Germany Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 31. Germany Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 32. Germany Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 33. France Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 34. France Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 35. France Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 36. Spain Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 37. Spain Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 38. Spain Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 39. Italy Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 40. Italy Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 41. Italy Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 42. ROE Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 43. ROE Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 44. ROE Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 45. China Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 46. China Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 47. China Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 48. India Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 49. India Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 50. India Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 51. Japan Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 52. Japan Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 53. Japan Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 54. Australia Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 55. Australia Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 56. Australia Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 57. South Korea Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 58. South Korea Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 59. South Korea Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 60. ROPAC Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 61. ROPAC Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 62. ROPAC Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 63. Brazil Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 64. Brazil Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 65. Brazil Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 66. Mexico Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 67. Mexico Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 68. Mexico Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 69. ROLA Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 70. ROLA Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 71. ROLA Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 72. ROW Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 73. ROW Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 74. ROW Nucleic Acid Amplification Testing (NAAT) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 75. List of secondary sources, used in the study of global Nucleic Acid Amplification Testing (NAAT) market
TABLE 76. List of primary sources, used in the study of global Nucleic Acid Amplification Testing (NAAT) market
TABLE 77. Years considered for the study
TABLE 78. Exchange rates considered

List of figures
FIG 1. Global Nucleic Acid Amplification Testing (NAAT) market, research methodology
FIG 2. Global Nucleic Acid Amplification Testing (NAAT) market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Nucleic Acid Amplification Testing (NAAT) market, key trends 2019
FIG 5. Global Nucleic Acid Amplification Testing (NAAT) market, growth prospects 2020-2027
FIG 6. Global Nucleic Acid Amplification Testing (NAAT) market, porters 5 force model
FIG 7. Global Nucleic Acid Amplification Testing (NAAT) market, pest analysis
FIG 8. Global Nucleic Acid Amplification Testing (NAAT) market, value chain analysis
FIG 9. Global Nucleic Acid Amplification Testing (NAAT) market by segment, 2017 & 2027 (USD Billion)
FIG 10. Global Nucleic Acid Amplification Testing (NAAT) market by segment, 2017 & 2027 (USD Billion)
FIG 11. Global Nucleic Acid Amplification Testing (NAAT) market by segment, 2017 & 2027 (USD Billion)
FIG 12. Global Nucleic Acid Amplification Testing (NAAT) market by segment, 2017 & 2027 (USD Billion)
FIG 13. Global Nucleic Acid Amplification Testing (NAAT) market by segment, 2017 & 2027 (USD Billion)
FIG 14. Global Nucleic Acid Amplification Testing (NAAT) market by segment, 2017 & 2027 (USD Billion)
FIG 15. Global Nucleic Acid Amplification Testing (NAAT) market by segment, 2017 & 2027 (USD Billion)
FIG 16. Global Nucleic Acid Amplification Testing (NAAT) market by segment, 2017 & 2027 (USD Billion)
FIG 17. Global Nucleic Acid Amplification Testing (NAAT) market, regional snapshot 2017 & 2027
FIG 18. North America Nucleic Acid Amplification Testing (NAAT) market 2017 & 2027 (USD Billion)
FIG 19. Europe Nucleic Acid Amplification Testing (NAAT) market 2017 & 2027 (USD Billion)
FIG 20. Asia-Pacific Nucleic Acid Amplification Testing (NAAT) market 2017 & 2027 (USD Billion)
FIG 21. Latin America Nucleic Acid Amplification Testing (NAAT) market 2017 & 2027 (USD Billion)
FIG 22. Global Nucleic Acid Amplification Testing (NAAT) market, company market share analysis (2019)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の核酸増幅検査(NAAT)市場2020年ー2027年:技術別(ターゲット増幅システム、プローブ増幅システム、シグナル増幅システム)、用途別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆